香港投资管理有限公司2月12日在香港会议展览中心宣布战略投资新风天域集团，双方签署协议，将合力加速推动跨地域医疗科研及临床应用的协作，更好地发挥香港在前沿的医疗科研、专业的医疗体系及高效的国际联系等强大优势，并联动粤港澳大湾区的人才和市场等庞大资源，携手推动香港作为国际医疗创新中心的加速发展。
Dear Vice President Professor Ian Holliday, Secretary of Health Prof Lo, Dean Professor Lau Chak Sing, Professor Rosie Young and Professor Felice Lieh Mak. Dear esteemed faculty members, graduates, families and friends. Good afternoon.
May 23, 2024, New Frontier Group (hereinafter referred to as “New Frontier”) announced that it had completed the acquisition of Hong Kong Integrated Oncology Center (hereinafter referred to as “HKIOC”), a leading comprehensive private oncology medical platform.
Through this acquisition, New Frontier will own HKIOC’s operations, including HKIOC Centre (Hong Kong Island), HKIOC Centre (Kowloon), and Hong Kong Adventist Hospital Oncology Center. HKIOC provides a full range of cancer treatment services, including early diagnosis, radiotherapy, systemic treatments, mental health, and other rehabilitation support services.
Conference participants group photo
HKIOC will join forces with New Frontier’s subsidiary, HEAL Oncology, to become one of Hong Kong’s leading private comprehensive oncology entities. HKIOC and HEAL Oncology, and United Family Healthcare, also a subsidiary of New Frontier, will work together to elevate cross-border cancer care. Through this partnership, surgeons, oncologists, and other allied health specialists will create a nationwide multidisciplinary cancer network.
This is one of Hong Kong’s most significant healthcare-related acquisitions in recent years. This acquisition is underpinned by New Frontier’s strong conviction in the supply and demand mismatch of the cancer population. New Frontier is committed to delivering word class solutions in this area.
Oncology care is one of the key growth pillars within New Frontier’s strategic roadmap. In light of this, New Frontier will provide patients with a full spectrum of cancer services that are both personalized and effective. To close the care gap, interventions must be made in the areas of screening and detection. Additionally, advanced drugs and treatment options such as targeted therapy, immunotherapy, and radiotherapy are capable of irradicating tumors more precisely while reducing collateral damage and side effects. Surrounding core cancer treatments, allied health services such as Traditional Chinese Medicine (“TCM”), mental health support, and physical rehabilitation can drastically improve patient experience and outcome.
This acquisition has unlocked deep sub-specializations across different cancer types. In addition, our multidisciplinary team (“MDT”) comprising of surgeons, oncologists, radiologists, pathologists, Radiation therapists, pharmacists, etc., will work together to formulate a precise and personalized treatment plan.
At the same time, clinical trials are a key step in promoting innovation and development of cancer treatment. New Frontier combines the professional knowledge and resources of HEAL Oncology and HKIOC to deliver larger-scale and pioneering.
New Frontier’s Presence in the GBA
The GBA is of high priority to New Frontier. Its current footprint in the region includes HEAL Medical Group, New Frontier Shenzhen United Family Hospital (“SZU”), Guangzhou United Family Hospital (“GZU”), and HKIOC; collectively referred to as “New Frontier Greater Bay Area Healthcare”, forming the backbone of the regional medical network.
1) HEAL Medical Groupis comprised of three specialty medical centres that provide patients with comprehensive medical services, including oncology, surgical intervention, internal medicine, TCM, fertility preservation, etc.
2) SZUis the first Hong Kong-funded private international hospital in Shenzhen, located in the CBD district of Futian. SZU has a multilingual medical team, 24-hour hotline, as well as bilingual medical reports to cater to regional medical tourism. In addition, many Hong Kong doctors have obtained mainland practicing licenses and attend medical sessions at SZU to bolster the clinical capability.
3) GZU, located in Haizhu district, is New Frontier’s first hospital in the GBA. Services covered include internal medicine, general surgery, obstetrics and gynecology, pediatrics, general practice, dermatology, dentistry, rehabilitation care, TCM, etc.
4) HKIOC possesses a full suite of and advanced imaging and radiotherapy equipment, PET-CT, CT, MRI, 3D mammography, ultrasound, linear accelerator (Linac), and
In addition to its comprehensive clinical services, New Frontier is steadfast in its commitment to furthering medical education and research. By fostering collaborations with esteemed academic and research institutions both domestically and internationally, the group actively engages in a range of medical education and research initiatives.
Co-founder & Group Chairman of New Frontier, Mr. Antony LEUNG
Mr. Antony LEUNG, the Co-Founder and Chairman of New Frontier Group, remarks,“Given the chronic and growing demand for quality cancer care in China, I’m grateful that we have found a partner who not only is a sector leader but also share our corporate mission of Doing good and Doing Well, with 4 Love.”
Co-founder & Group CEO of New Frontier, CEO of United Family Heralthcare Mr. Carl WU
Carl Wu, Group CEO & Co-founder of New Frontier Group, CEO of United Family Healthcare expresses, “We will leverage synergies across our subsidiaries to create an advanced and robust healthcare ecosystem. The acquisition of HKIOC gives us incredible depth of expertise to treat the most common, as well as the rarest forms of cancer. Our investment in research and academia will accelerate our effort in tackling the greatest health crisis of our time.”
Co-founder of Hong Kong Integrated Oncology Centre, Prof. Ronnie POON
Prof. Ronnie Poon Tung-ping, founder of Hong Kong Integrated Oncology Centre, believes, “I am thrilled that HKIOC has joined New Frontier Group, a moment that fills entire team with tremendous pride. This partnership is a recognition of our accomplishments and growth as a comprehensive oncology diagnostic and medical center since our establishment in 2015. The integration into New Frontier Group presents a significant opportunity to contribute to the medical development of the Greater Bay Area, and I hope our centres, along with the entire group, can lay a solid foundation in oncology for decades to come.”
–
About New Frontier Group
New Frontier Group was founded in 2016 by Mr. Antony Leung, former Financial Secretary of Hong Kong, and Mr. Carl Wu, former Managing Director at Blackstone, with the goal of addressing some of the most pressing healthcare needs today.In the short time since its founding, New Frontier Group has become one of the leading private healthcare service providers in Greater China, offering a comprehensive range of services that span across the entire healthcare continuum.
This includes general and specialty healthcare, rehabilitation care, home care, health insurance services, health technology, and more. Currently, the group operates 32 hospitals with over 9,000 beds, serving 77 cities. It is supported by a dedicated workforce of approximately 12,000 full-time staff, including over 3,000 doctors and more than 2,000 nursing staff. This year, the group expects to exceed 12 million patient visits, with in-patient days totaling 1.9 million. Please visit https://www.new-frontier.com/en/ for more information.
–
About United Family Healthcare
United Family Healthcare (UFH), a New Frontier Group subsidiary, is an international hospital and clinic network that has been providing private, premium healthcare in China since 1997. Today, UFH has established a strong presence in the region, operating 10 hospitals, 1 internet hospital, and 24 clinics across the country. The UFH team currently comprises approximately 1000 full-time doctors from over 30 countries and is supported by a dedicated group of over 1,500 nurses. Please visit https://ufh.com.cn/en/ for more information.
–
About HEAL Oncology HEAL
Oncology Limited, also a New Frontier Group subsidiary, is a private oncology centre located in Hong Kong’s Central district. The centre offers an extensive array of oncology services accompanied by a diverse range of allied health services. HEAL Oncology is an essential component of HEAL Group, which also includes HEAL Medical Centre (a multispecialty clinic) and HEAL Fertility Centre (an assisted reproductive medicine clinic). These centres are all located within walking distance of each other for convenient patient access, facilitating a multidisciplinary approach to provide comprehensive and personalized treatment. Please visit www.heal-medical.com for more information.
–
About Hong Kong Integrated Oncology Centre
Established in 2015, the Hong Kong Integrated Oncology Centre (HKIOC) and the Hong Kong Integrated Diagnostic Imaging Centre have been dedicated to providing quality and holistic multidisciplinary specialist services for cancer diagnosis, treatment and wellness services. Since 2016, HKIOC has forged a strategic partnership with the Hong Kong Adventist Hospital Oncology Centre (HKAOC), introducing 6 the concept of day care cancer treatment that entails integrated services across disciplines. Cancer patients could choose to receive treatment in HKIOC’s day care centre at their convenience, and be referred to HKAOC located in Stubbs Road if needed. With a range of state-of-the-art radiotherapy including TomoTherapy and Y90 radioembolization, HKAOC provides quality in-patient services and emergency hospital care. Please visit www.hkioc.com.hk for more information.
HKUST Business School and Tsinghua University’s PBC School of Finance (PBCSF) recently entered into a strategic partnership, aiming to cultivate high-caliber talent and advance finance and technology education in the region.
On November 2, a signature BizInsight Forum co-hosted by both parties in Beijing kick-started the strategic collaboration. Titled “The Future and Innovation Forum”, the event brought together academia leaders and industry professionals for a dynamic exchange of ideas.
Keynote speakers, including Dean of Tsinghua Weixian College Prof. HONG Bo (left), Dean of HKUST Academy of Interdisciplinary Studies Prof. QU Huamin (middle), and CEO of New Frontier Health and United Family Healthcare Mr. Carl WU (right), explored cutting-edge topics such as the breakthroughs in brain-computer interface technology, AI-driven interdisciplinary innovation, and the application of AI technologies in the healthcare industry. Two engaging panel sessions also gathered leaders to discuss pivotal advancements in life sciences and the transformative impact of AI in business.
Moderated by HKUST’s Associate Dean (Strategic Planning and Research) Prof. LOU Dong (first right), the first panel discussed how technology and data integration drive healthcare innovation and balance privacy with personalized care. The speakers were Prof. Hong Bo (first left); Founder of Shenzhen XpectVision Technology Co., LTD Mr. CAO Peiyan (second right); Chairman of Hinova Pharma Mr. CHEN Yuanwei (second left); and Mr. Carl Wu (middle).
The second panel, led by Assistant of the Dean of Tsinghua PBCSF Prof. LIU Bibo (first right), focused on AI ethics, cloud-AI integration, and future trends in AI investment and commercial applications. The speakers were 4Paradigm’s Co-founder Mr. HU Shiwei (second right); Managing Director of Lenovo Capital and Incubator Group Ms. Cindy LIANG (middle); VP of Inspur Group Mr. LIU Hui (second left); and Prof. Qu Huamin (first left).
2024年6月22日，妙佑医疗国际（Mayo Clinic） 正式宣布中国首个妙佑医疗国际代表处落址和睦家上海院区内。同时，新风天域也宣布启动国际医疗服务中心，为国内外患者提供一体化就诊服务。
未来，新风天域/和睦家医疗和妙佑医疗国际将持续建立在联合治疗、国际学术交流、临床培训和临床药物研发等方面的长期合作，共同链接全球前沿的医疗资源，为患者福祉而不懈努力。
The Hong Kong Medical Association (“HKMA”) today signed a Memorandum of Understanding (“MoU”) on cooperation with the United Family Healthcare (“UFH”) to establish a “Pilot Programme for Medical Talent Training and Exchange between Hong Kong and the Mainland”. This allows Hong Kong medical students to train at mainland hospitals while also launching CME courses for doctors in both regions to participate, broadening talent exchange reach.
May 23, 2024, New Frontier Group (hereinafter referred to as “New Frontier”) announced that it had completed the acquisition of Hong Kong Integrated Oncology Center (hereinafter referred to as “HKIOC”), a leading comprehensive private oncology medical platform.